Les actions de Celldex chutent à mesure que les problèmes de sécurité assombrissent le succès d'un essai de médicament cutané
Tap title to read story
0:00 / 1:13
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story